Intuitive Surgical Inc.

ISRG-Q

NASDAQ:ISRG

692.93
0.23 (0.03%)
Intuitive Surgical Inc. is an American corporation that develops, manufactures and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
More at Wikipedia

Analysis and Opinions about ISRG-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
September 4, 2020
(A Top Pick Aug 19/19, Up 49%) A leader in robotic surgery. It provides a better surgical experience with more precise surgeries. The long-term story is that right now, robotic surgery accounts for 4% of surgeries right now. They have a huge head start in this domain and have great cashflow.
Show full opinionHide full opinion
(A Top Pick Aug 19/19, Up 49%) A leader in robotic surgery. It provides a better surgical experience with more precise surgeries. The long-term story is that right now, robotic surgery accounts for 4% of surgeries right now. They have a huge head start in this domain and have great cashflow.
BUY
BUY
August 31, 2020

JNJ JNJ is trying to respond to the rise of robotic surgery by Intuitive Surgical, which he prefers. This take time and research for JNJ, which means Intuitive will still be ahead of JNJ.

Show full opinionHide full opinion

JNJ JNJ is trying to respond to the rise of robotic surgery by Intuitive Surgical, which he prefers. This take time and research for JNJ, which means Intuitive will still be ahead of JNJ.

BUY
BUY
August 25, 2020
Allan Tong’s Discover Picks Both Jamie Murray and Bruce Murray (unrelated) see strong long-term growth ahead for the company as more surgeons adapt robotic devices. ISRG's market share is currently only 4%, but Bruce Murray expects the company to grow 50% next year and 20% after that. However, investors have already caught onto this stock and ISRG stock has almost doubled from the March 23 bottom; it has passed its $655 price target and is flirting with $700. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
Show full opinionHide full opinion
Allan Tong’s Discover Picks Both Jamie Murray and Bruce Murray (unrelated) see strong long-term growth ahead for the company as more surgeons adapt robotic devices. ISRG's market share is currently only 4%, but Bruce Murray expects the company to grow 50% next year and 20% after that. However, investors have already caught onto this stock and ISRG stock has almost doubled from the March 23 bottom; it has passed its $655 price target and is flirting with $700. Read BDX, BSX, ISRG and Stryker Stock: Top 4 Medical Supply Stocks for our full analysis.
TOP PICK
TOP PICK
August 24, 2020
The leader in robotic surgery. They have only a 3-5% market share, but will grow as doctors grow more comfortable with robotic surgery. The PE is high, but the growth rate will catch up. He sees 50% growth next year and 20% after. This is a high-growth stock. (Analysts’ price target is $655.19)
Show full opinionHide full opinion
The leader in robotic surgery. They have only a 3-5% market share, but will grow as doctors grow more comfortable with robotic surgery. The PE is high, but the growth rate will catch up. He sees 50% growth next year and 20% after. This is a high-growth stock. (Analysts’ price target is $655.19)
PAST TOP PICK
PAST TOP PICK
July 14, 2020
(A Top Pick Aug 19/19, Up 15%) They lead in robotic-assisted surgery, though ISRG has only 4% market penetration. They generate tons of cash with lots of recurring revenue. As more surgeries go robotic in the next 20 years, ISRG will lead the way. Buy and put this away for 20 years.
Show full opinionHide full opinion
(A Top Pick Aug 19/19, Up 15%) They lead in robotic-assisted surgery, though ISRG has only 4% market penetration. They generate tons of cash with lots of recurring revenue. As more surgeries go robotic in the next 20 years, ISRG will lead the way. Buy and put this away for 20 years.
TOP PICK
TOP PICK
April 17, 2020
The maker of surgical robots. They are the leader in the sector and there is no real competition. With only 5% of surgeries being done robotically there is enormous growth ahead. Yield 0% (Analysts’ price target is $546.67)
Show full opinionHide full opinion
The maker of surgical robots. They are the leader in the sector and there is no real competition. With only 5% of surgeries being done robotically there is enormous growth ahead. Yield 0% (Analysts’ price target is $546.67)
TOP PICK
TOP PICK
January 2, 2020
The leader in robotic surgery. They sold about 900 units. He thinks they will continue to grow world-wide. (Analysts’ price target is $612.34)
Show full opinionHide full opinion
The leader in robotic surgery. They sold about 900 units. He thinks they will continue to grow world-wide. (Analysts’ price target is $612.34)
TOP PICK
TOP PICK
August 19, 2019
It is the largest company that you have never heard of. Their business is robots for surgery. It has been under a bit of pressure from a competitor but that competitor only has 4% penetration globally. (Analysts’ price target is $572.35)
Show full opinionHide full opinion
It is the largest company that you have never heard of. Their business is robots for surgery. It has been under a bit of pressure from a competitor but that competitor only has 4% penetration globally. (Analysts’ price target is $572.35)
COMMENT
COMMENT
June 12, 2019

Medical robotics? He does not know TMD-T well. He plays the space through and ETF of BOTZ-Q. He prefers ISRG-Q, if you wanted an individual holding.

Show full opinionHide full opinion

Medical robotics? He does not know TMD-T well. He plays the space through and ETF of BOTZ-Q. He prefers ISRG-Q, if you wanted an individual holding.

COMMENT
COMMENT
April 17, 2019
Own it through an ETF called BOTZ. That is the way he likes to play into the robotics / machine learning space.
Show full opinionHide full opinion
Own it through an ETF called BOTZ. That is the way he likes to play into the robotics / machine learning space.
TOP PICK
TOP PICK
April 18, 2018

A disruptor in medtech. ISRG builds robotic-assisted surgical devices that are sold to hospitals. Enjoys 85% recurring revenues. Growing steadily for 20 years with good intenational exposure. Their commerical shows a robot sewing the skin on a grape. Stock rose 8% today alone. Again demographics are another tailwind. (Also look at the IHI ETF in the medtech sector.) (Analysts' price target $460.80)

Show full opinionHide full opinion

A disruptor in medtech. ISRG builds robotic-assisted surgical devices that are sold to hospitals. Enjoys 85% recurring revenues. Growing steadily for 20 years with good intenational exposure. Their commerical shows a robot sewing the skin on a grape. Stock rose 8% today alone. Again demographics are another tailwind. (Also look at the IHI ETF in the medtech sector.) (Analysts' price target $460.80)

DON'T BUY
DON'T BUY
February 5, 2013

Have the robotic methodology for surgical procedures, which has been very successful but it is priced in. Great company. Trading at 35X earnings which is too expensive.

Show full opinionHide full opinion

Have the robotic methodology for surgical procedures, which has been very successful but it is priced in. Great company. Trading at 35X earnings which is too expensive.

DON'T BUY
DON'T BUY
January 11, 2012
Surgical tool for surgeons to use like a robot. He is worried about it getting well ahead of itself. If anything goes wrong there is a lot of air under that stock price.
Show full opinionHide full opinion
Surgical tool for surgeons to use like a robot. He is worried about it getting well ahead of itself. If anything goes wrong there is a lot of air under that stock price.
DON'T BUY
DON'T BUY
January 13, 2010
A high-growth story but too expensive for him now. High beta of 1.3.
Show full opinionHide full opinion
A high-growth story but too expensive for him now. High beta of 1.3.
Showing 1 to 14 of 14 entries
  • «
  • 1
  • »

Intuitive Surgical Inc.(ISRG-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Intuitive Surgical Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Intuitive Surgical Inc.(ISRG-Q) Frequently Asked Questions

What is Intuitive Surgical Inc. stock symbol?

Intuitive Surgical Inc. is a American stock, trading under the symbol ISRG-Q on the NASDAQ (ISRG). It is usually referred to as NASDAQ:ISRG or ISRG-Q

Is Intuitive Surgical Inc. a buy or a sell?

In the last year, 4 stock analysts published opinions about ISRG-Q. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is PAST TOP PICK. Read the latest stock experts' ratings for Intuitive Surgical Inc..

Is Intuitive Surgical Inc. a good investment or a top pick?

Intuitive Surgical Inc. was recommended as a Top Pick by Jamie Murray on 2020-09-04. Read the latest stock experts ratings for Intuitive Surgical Inc..

Why is Intuitive Surgical Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Intuitive Surgical Inc. worth watching?

4 stock analysts on Stockchase covered Intuitive Surgical Inc. In the last year. It is a trending stock that is worth watching.

What is Intuitive Surgical Inc. stock price?

On 2020-09-29, Intuitive Surgical Inc. (ISRG-Q) stock closed at a price of $692.93.